跳至主要内容
临床试验/ISRCTN10948363
ISRCTN10948363已完成不适用

Experimental Human Pneumococcal Carriage (Programme Grant) Research: working towards a nasal vaccine for pneumonia. The effect of age on immune function

iverpool School of Tropical Medicine0 个研究点目标入组 74 人开始时间: 2016年11月8日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Adults (male or female) aged 50-84 years
  • 2. Fluent spoken English - to ensure a comprehensive understanding of the research project and their proposed involvement
  • 3. World Health Organisation performance status 0 (able to carry out all normal activity without restriction) or 1 (restricted in strenuous activity but ambulatory and able to carry out light work)
  • 4. Access to telephone (safety and timely communication)
  • 5. Capacity to give informed consent

排除标准

  • 1. Close physical contact with at risk individuals (children under 5yrs, immunosuppressed adults) - minimise risk of pneumococcal transmission
  • 2. History of drug or alcohol abuse (frequently drinking over the recommended alcohol intake limit: men and women should not regularly drink > 3-4 units/day and >2-3 units/day respectively) – minimise risk of pneumococcal disease
  • 3. Smoking any cigarettes currently or within the last six months - minimise risk of pneumococcal disease
  • 4. Ex-smoker with a significant smoking history (>10 pack years) – minimise risk of pneumococcal disease
  • 5. Any current treatment for asthma – confounding effect of medications such as corticosteroids, and propensity to infection
  • 6. Taking daily medications that may affect the immune system e.g. steroids, steroid nasal spray, antibiotics, disease modifying anti-rheumatoid drugs
  • 7. Any acute illness (new symptoms within preceding 14 days which are unexplained by the known past medical history)
  • 8. Having received any antibiotics in the preceding 28 days
  • 9. Taking medication that affects blood clotting e.g. aspirin, clopidogrel, warfarin or other oral or injectable anticoagulants
  • 10. History of culture-proven pneumococcal disease
  • 11. Allergy to penicillin/amoxicillin
  • 12. Involved in another clinical trial unless observational or in follow-up (non-interventional) phase.
  • 13. Have been involved in a clinical trial involving EHPC and bacterial inoculation in the past three years
  • 14. Significant cardiorespiratory disease (excluding stable hypertension)
  • 15. Disease associated with altered immunity, including diabetes, alcohol abuse, malignancy, rheumatological conditions
  • 16. Taking any medications except those on the allowed list”:statins; antihypertensives in stable hypertension; antidepressants; bisphosphonates; treatment for benign prostatic hyperplasia; hormone replacement therapy; vitamin supplements (including multivitamins, iron); anti-acid medications; nicotine replacement therapy (NRT)

研究者

发起方
iverpool School of Tropical Medicine

相似试验